Serpin latency transition at atomic resolution

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 43, 2014, Pages 1514-1519

  Cazzolli, Giorgia ^a,b   Wang, Fang ^c   Beccara, Silvio A ^b,d   Gershenson, Anne ^e   Faccioli, Pietro ^a,b   Wintrode, Patrick L ^c  

^a UNIVERSITY OF TRENTO   (Italy)

^b INFN TIFPA   (Italy)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^d FONDAZIONE BRUNO KESSLER   (Italy)

^e UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Conformational change; Molecular simulations; Plasminogen activator inhibitor 1

Indexed keywords

LIGAND; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRYPSIN INHIBITOR;

ARTICLE; ATOM; CHEMICAL REACTION KINETICS; CONFORMATIONAL TRANSITION; FORCE; LATENCY TRANSITION; MUTATION; OPTICAL RESOLUTION; PHASE TRANSITION; PROTEIN CONFORMATION; PROTEIN STRUCTURE; REACTION ANALYSIS; SIMULATION;

EID: 84908574972     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1407528111     Document Type: Article

References (47)

1. Van De Craen B, Declerck PJ, Gils A (2012) The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo. Thromb Res 130(4):576-585.
2. Huntington JA, Read RJ, Carrell RW (2000) Structure of a serpin-protease complex shows inhibition by deformation. Nature 407(6806):923-926.
3. Lindahl TL, Sigurdardottir O, Wiman B (1989) Stability of plasminogen activator inhibitor 1 (PAI-1). Thromb Haemost 62(2):748-751.
4. Lin Z, et al. (2013) Structural insight into inactivation of plasminogen activator inhibitor-1 by a small-molecule antagonist. Chem Biol 20(2):253-261.
5. Fjellström O, et al. (2013) Characterization of a small molecule inhibitor of plasminogen activator inhibitor type 1 that accelerates the transition into the latent conformation. J Biol Chem 288(2):873-885.
6. Shaw DE, et al. (2010) Atomic-level characterization of the structural dynamics of proteins. Science 330(6002):341-346.
7. Elber R, West A (2010) Atomically detailed simulation of the recovery stroke in myosin by Milestoning. Proc Natl Acad Sci USA 107(11):5001-5005.
8. Shimamura T, et al. (2010) Molecular basis of alternating access membrane transport by the sodium-hydantoin transporter Mhp1. Science 328(5977):470-473.
9. Biarnés X, Bongarzone S, Vargiu AV, Carloni P, Ruggerone P (2011) Molecular motions in drug design: The coming age of the metadynamics method. J Comput Aided Mol Des 25(5):395-402.
10. Ovchinnikov V, Karplus M, Vanden-Eijnden E (2011) Free energy of conformational transition paths in biomolecules: The string method and its application to myosin VI. J Chem Phys 134(8):085103.
11. Moradi M, Tajkhorshid E (2013) Mechanistic picture for conformational transition of a membrane transporter at atomic resolution. Proc Natl Acad Sci USA 110(47): 18916-18921.
12. Krüger P, Verheyden S, Declerck PJ, Engelborghs Y (2001) Extending the capabilities of targeted molecular dynamics: Simulation of a large conformational transition in plasminogen activator inhibitor 1. Protein Sci 10(4):798-808.
13. Faccioli P, Sega M, Pederiva F, Orland H (2006) Dominant pathways in protein folding. Phys Rev Lett 97(10):108101.
14. a Beccara S, -Skrbi-c T, Covino R, Micheletti C, Faccioli P (2013) Folding pathways of a knotted protein with a realistic atomistic force field. PLoS Comput Biol 9(3): e1003002.
15. a Beccara S, -Skrbi-c T, Covino R, Faccioli P (2012) Dominant folding pathways of a WW domain. Proc Natl Acad Sci USA 109(7):2330-2335.
16. Faccioli P (2008) Characterization of protein folding by dominant reaction pathways. J Phys Chem B 112(44):13756-13764.
17. Faccioli P, Lonardi A, Orland H (2010) Dominant reaction pathways in protein folding: A direct validation against molecular dynamics simulations. J Chem Phys 133(4): 045104.
18. Gorlatova NV, Elokdah H, Fan K, Crandall DL, Lawrence DA (2003) Mapping of a conformational epitope on plasminogen activator inhibitor-1 by random mutagenesis. Implications for serpin function. J Biol Chem 278(18):16329-16335.
19. Hägglöf P, Bergström F, Wilczynska M, Johansson LB-Å, Ny T (2004) The reactivecenter loop of active PAI-1 is folded close to the protein core and can be partially inserted. J Mol Biol 335(3):823-832.
20. Dupont DM, et al. (2006) Evidence for a pre-latent form of the serpin plasminogen activator inhibitor-1 with a detached β-strand 1C. J Biol Chem 281(47):36071-36081.
21. Berkenpas MB, Lawrence DA, Ginsburg D (1995) Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J 14(13):2969-2977.
22. Hansen M, Busse MN, Andreasen PA (2001) Importance of the amino-acid composition of the shutter region of plasminogen activator inhibitor-1 for its transitions to latent and substrate forms. Eur J Biochem 268(23):6274-6283.
23. Lomas DA, Elliott PR, Chang W-SW, Wardell MR, Carrell RW (1995) Preparation and characterization of latent α1-antitrypsin. J Biol Chem 270(10):5282-5288.
24. Im H, Woo M-S, Hwang KY, Yu M-H (2002) Interactions causing the kinetic trap in serpin protein folding. J Biol Chem 277(48):46347-46354.
25. Elber R, Shalloway D (2000) Temperature dependent reaction coordinates. J Chem Phys 112:5539.
26. Brown NJ (2010) Therapeutic potential of plasminogen activator inhibitor-1 inhibitors. Ther Adv Cardiovasc Dis 4(5):315-324.
27. Maddur AA, Swanson R, Izaguirre G, Gettins PGW, Olson ST (2013) Kinetic intermediates en route to the final serpin-protease complex: Studies of complexes of α1-protease inhibitor with trypsin. J Biol Chem 288(44):32020-32035.
28. Tsutsui Y, Liu L, Gershenson A, Wintrode PL (2006) The conformational dynamics of a metastable serpin studied by hydrogen exchange and mass spectrometry. Biochemistry 45(21):6561-6569.
29. Trelle MB, et al. (2012) Hydrogen/deuterium exchange mass spectrometry reveals specific changes in the local flexibility of plasminogen activator inhibitor 1 upon binding to the somatomedin B domain of vitronectin. Biochemistry 51(41):8256-8266.
30. Lee KN, Im H, Kang SW, Yu MH (1998) Characterization of a human α1-antitrypsin variant that is as stable as ovalbumin. J Biol Chem 273(5):2509-2516.
31. Baek J-H, Yang WS, Lee C, Yu M-H (2009) Functional unfolding of α1-antitrypsin probed by hydrogen-deuterium exchange coupled with mass spectrometry. Mol Cell Proteomics 8(5):1072-1081.
32. Trelle MB, Madsen JB, Andreasen PA, Jørgensen TJD (2014) Local transient unfolding of native state PAI-1 associated with serpin metastability. Angew Chem Int Ed Engl 53(37):9751-9754.
33. Seo EJ, Lee C, Yu M-H (2002) Concerted regulation of inhibitory activity of α1-antitrypsin by the native strain distributed throughout the molecule. J Biol Chem 277(16): 14216-14220.
34. Li S-H, et al. (2013) Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1. Proc Natl Acad Sci USA 110(51):E4941-E4949.
35. Zhou A, Huntington JA, Pannu NS, Carrell RW, Read RJ (2003) How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. Nat Struct Biol 10(7):541-544.
36. Irving JA, Pike RN, Lesk AM, Whisstock JC (2000) Phylogeny of the serpin superfamily: Implications of patterns of amino acid conservation for structure and function. Genome Res 10(12):1845-1864.
37. Xue Y, et al. (1998) Interfering with the inhibitory mechanism of serpins: Crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide. Structure 6(5):627-636.
38. Wang J, Cieplak P, Kollman PA (2000) How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J Comput Chem 21:1049-1074.
39. Hess B, Kutzner C, van der Spoel D, Lindahl E (2008) GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4:435-447.
40. Onufriev A, Bashford D, Case DA (2004) Exploring protein native states and largescale conformational changes with a modified generalized Born model. Proteins 55(2):383-394.
41. Stout TJ, Graham H, Buckley DI, Matthews DJ (2000) Structures of active and latent PAI-1: A possible stabilizing role for chloride ions. Biochemistry 39(29):8460-8469.
42. Elliott PR, Pei XY, Dafforn TR, Lomas DA (2000) Topography of a 2.0 A structure of α1 -antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci 9(7):1274-1281.
43. Fiser A, Sali A (2003) ModLoop: Automated modeling of loops in protein structures. Bioinformatics 19(18):2500-2501.
44. Lauck F, Smith CA, Friedland GF, Humphris EL, Kortemme T (2010) RosettaBackrub-A web server for flexible backbone protein structure modeling and design. Nucleic Acids Res 38(Web Server issue):W569-W75.
45. Paci E, Karplus M (1999) Forced unfolding of fibronectin type 3 modules: An analysis by biased molecular dynamics simulations. J Mol Biol 288(3):441-459.
46. Camilloni C, Broglia RA, Tiana G (2011) Hierarchy of folding and unfolding events of protein G, CI2, and ACBP from explicit-solvent simulations. J Chem Phys 134(4): 045105.
47. Trott O, Olson AJ (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455-461.